NCT03377465View on ClinicalTrials.gov

Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

December 5, 2017

Conditions
Embolic Stroke of Undetermined SourceIschemic StrokeAtrial Fibrillation and FlutterMyocardial InfarctionCardiac TumorEndocarditisPatent Foramen Ovale
Interventions
DIAGNOSTIC_TEST

ADMA (asymmetric dimethylarginine) , NTproBNP (N-terminal pro b-type natriuretic peptide), IL-6 (Interleukin 6), Adiponectina, Leptine, Syndecan, Resistin

ADMA, NTproBNP, IL-6, Adiponectina, Leptine, Syndecan, Resistin

All Listed Sponsors
lead

Medical University of Lodz

OTHER

NCT03377465 - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis | Biotech Hunter | Biotech Hunter